Profile
SPRC VRTX REGN SGEN ARGX ALNY
Company Name SciSparc Ltd. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.03M $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.00K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Mr. Itschak Shrem Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
SPRC VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 2 4 3 3 1
Quant Rating Sell Sell Buy Neutral Neutral Strong Sell
Trading
SPRC VRTX REGN SGEN ARGX ALNY
Last Close $0.35 $429.6 $547.67 $228.74 $569.12 $258.35
High 52 $1.28 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.21 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High -72.66 % -16.86 % -54.43 % 0 % -15.28 % -12.94 %
Price vs. 52 Week Low 66.67 % 8.31 % 0.23 % 0 % 59.86 % 75.83 %
Total Return
SPRC VRTX REGN SGEN ARGX ALNY
1 Month Return 27.04 % -10.93 % -4.95 % 0 % 0.94 % 6.21 %
3 Month Return -26.33 % -8.46 % -22.81 % 0 % -11.99 % -6.46 %
6 Month Return 47.06 % -16.86 % -33.89 % 0 % -4.51 % -6.88 %
9 Month Return 12.9 % -8.29 % -51.59 % 0 % 6.38 % -4.14 %
YTD Return -2.78 % 6.68 % -23.12 % 0 % -7.46 % 9.79 %
1 Year Return -72.66 % 2.53 % -43.42 % 0 % 48.77 % 70.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SPRC VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -4851 % -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
SPRC VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 45.62 % 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -54.23 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -78.22 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM 84.95 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 85.78 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM -89.84 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM 422.15 % -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -7579.69 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM 91.95 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 0.82 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM 2.29 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM 2393.15 % 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM 16.67 % 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -2.4 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -2.4 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 126.44 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM -277.68 % -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.02 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -7579.69 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -0.62 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -0.12 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -0.12 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
SPRC VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 76.28% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.01B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -12.55 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
SPRC VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $0.01B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.01B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
SPRC VRTX REGN SGEN ARGX ALNY
Net Income $-0.01B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $-0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.21
ABCL AbCellera Biologics Inc. 2.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.48
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.0101
ABPWW 0.02
ABSI Absci Corporation 2.835
ABUS Arbutus Biopharma Corporation 3.345
ABVC ABVC BioPharma, Inc. 1.3299
ABVX Abivax SA American Depositary Shares 6.91
ACAD ACADIA Pharmaceuticals Inc. 17.14
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.5636
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.475
ACIU AC Immune SA 1.69
ACLX Arcellx, Inc. 57.31
ETFs With Exposure to SPRC
Ticker ETF Name Weight Percentage Price
AVEM Avantis Emerging Markets Equity ETF 0 62.41
AVES Avantis Emerging Markets Value ETF 0 49.0728
AVEE American Century Etf Trust - Avantis Emerging Markets Small Cap Equiy Etf 0.07 54.87
AVXC Avantis Emerging Markets ex-China Equity ETF 0 51.49
Unlock